
The State of Multiple Sclerosis Treatment
Advertisement
Advertisement
Trending on NeurologyLive - Clinical Neurology News and Neurology Expert Insights
1
Autopsy Study Demonstrates Tofersen Distribution and SOD1 Reduction in SOD1-ALS
2
Advancing Multiple Sclerosis Treatment Through Research-Integrated Clinical Care
3
Tazbentetol Shows Durable Cognitive Benefit Through 84 Weeks in Alzheimer Disease
4
Clinical Utility and Practical Challenges of OCT in the 2024 McDonald Criteria for MS: Rachel Kenney, PhD
5

